Inhibition of hematopoietic prostaglandin D2 Synthase (H-PGDS) by an alkaloid extract from Combretum molle

BMC Complementary and Alternative Medicine

Stanley Mukanganyama¹  Theresa Chimponda²  Rejoice Moyo³ 

[1] Biomolecular Interactions Analyses Group, Department of Biochemistry, University of Zimbabwe, P.O. Box MP 167, Mt. Pleasant, Harare, Zimbabwe;Department of Biochemistry, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe;School of Pharmacy, College of Health Sciences, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe

关键词: Hematopoietic prostaglandin D₂ synthase;    Alkaloid;    Combretum molle;   

Others  :  1087471
DOI  :  10.1186/1472-6882-14-221

 received in 2014-02-06, accepted in 2014-06-30,  发布年份 2014

【 摘 要 】

Background

Hematopoietic prostaglandin D₂ synthase (H-PGDS, GST Sigma) is a member of the glutathione S-transferase super family of enzymes that catalyses the conjugation of electrophilic substances with reduced glutathione. The enzyme catalyses the conversion of PGH₂ to PGD₂ which mediates inflammatory responses. The inhibition of H-PGDS is of importance in alleviating damage to tissues due to unwarranted synthesis of PGD₂. Combretum molle has been used in African ethno medicinal practices and has been shown to reduce fever and pain. The effect of C. molle alkaloid extract on H-PGDS was thus, investigated.

Methods

H-PGDS was expressed in Escherichia coli XL1-Blue cells and purified using nickel immobilized metal affinity chromatography. The effect of C. molle alkaloid extract on H-PGDS activity was determined with 1-chloro-2, 4-dinitrobenzene (CDNB) as substrate. The effect of C. molle alkaloid extract with time on H-PGDS was determined. The mechanism of inhibition was then investigated using CDNB and glutathione (GSH) as substrates.

Results

A specific activity of 24 μmol/mg/min was obtained after H-PGDS had been purified. The alkaloid extract exhibited a 70% inhibition on H-PGDS with an IC₅₀ of 13.7 μg/ml. C. molle alkaloid extract showed an uncompetitive inhibition of H-PGDS with K_i = 41 μg/ml towards GSH, and non-competitive inhibition towards CDNB with K_i = 7.7 μg/ml and K_i^′ = 9.2 μg/ml.

Conclusion

The data shows that C. molle alkaloid extract is a potent inhibitor of H-PGDS. This study thus supports the traditional use of the plant for inflammation.

【 授权许可】

   
2014 Moyo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Arya V, Arya ML: A review on anti-inflammatory plant barks. Int J PharmTech Res 2011, 3:899-908.
• [2]Trivedi SG, Newson J, Rajakariar R, Jacques TS, Hannon R, Kanaoka Y, Eguchi N, Colville-Nash P, Gilroy DW: Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc Natl Acad Sci 2006, 103:5179-5184.
• [3]Shailasree S, Ruma K, Kini KR, Niranjana SR, Prakash HS: Potential anti-inflammatory bioactives from medicinal plants of Western Ghats, India. Phcog Commn 2012, 2:1-12.
• [4]Mueller M, Hobiger S, Jungbauer A: Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem 2010, 122:987-996.
• [5]Joo LM, Sadikot RT: PGD synthase and PGD2 in immune response. Mediat Inflamm 2012, Article ID 503128:1-6.
• [6]LaCourse EJ, Perally S, Morphew RM, Moxon JV, Prescott M: The sigma class glutathione transferase from the liver fluke Fasciola hepatica. PLoS Negl Trop Dis 2012, 6:1666.
• [7]Jagessar RC, Mars A, Gomes G: Selective antimicrobial properties of Phyllanthus acidus leaf extract against Candida albicans, Escherichia coli and Staphylococcus aureus using stokes disc diffusion, well diffusion, streak plate and a dilution method. Nat Sci 2008, 6:24-38.
• [8]Kanaoka Y, Ago H, Inagaki E: Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 1997, 90:1085-1095.
• [9]Christ AN, Labzin L, Bourne G: Development and characterization of new inhibitors of the human and mouse hematopoietic prostaglandin D2 synthases. J Med Chem 2010, 53:5536-5548.
• [10]Kainsa S, Bhoria R: Medicinal plants as a source of anti-inflammatory agent: a review. IJAHM 2012, 2:499-509.
• [11]Anilkumar M: Ethnomedicinal plants as anti-inflammatory and analgesic agents. Ethnomed: A Source Complement Ther 2010, 267-293.
• [12]Nyenje N: Bioactivity of the acetone extract of the stem bark of Combretum molle on selected bacterial pathogens: preliminary phytochemical screening. JMPR 2012, 6:1476-1481.
• [13]Chigora P, Masocha R, Mutenheri F: The role of indigenous medicinal knowledge (IMK) in the treatment of ailments in rural zimbabwe: the case of Mutirikwi communal lands. J Sustain Dev Af 2007, 9:26-43.
• [14]Ojewole JA: Analgesic and anti-inflammatory effects of mollic acid glucoside, a 1alpha-hydroxycycloartenoid saponin extractive from Combretum molle (Combretaceae) leaf. Phytother Res 2008, 22:30-35.
• [15]Yeo M, Han SU, Nam KT, Kim DY, Cho SW, Hahm KB: Acute and sub-acute toxic study of aqueous leaf extract of Combretum molle. Trop J Pharm Res 2012, 11:217-223.
• [16]McGaw LJ, Rabe T, Sparg SG, Jager AK, Eloff JN, Staden J: An investigation on the biological activity of Combretum species. J Ethnopharmacol 2001, 75:45-50.
• [17]Shah B, Shah N, Seth AK, Maheshwari KM: A review on medicinal plants as a source of anti-inflammatory agents. Res J Med Plants 2011, 5:101-115.
• [18]Dodehe Y, Koffi E, Philippe BA, Tako NM, Calixte B, Souleymane M, Joseph DA, Guéde-Guina F: In vitro anticholinesterase and inhibitory effects of the aqueous extract of Combretum molle (Combretaceae) leaf on rabbit breathing. Trop J Pharm Res 2010, 9:469-473.
• [19]Mukanganyama S, Widersten M, Naik YS, Mannervik B, Hasler JA: Inhibition of Glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer 2002, 97:700-705.
• [20]Whiteley CG: Enzyme kinetics: partial and complete uncompetitive inhibition. Biochem Educ 2000, 28:144-147.
• [21]Phanse MA, Patil MJ, Abbulu K, Chaudhari PD, Patel B: In-vivo and in-vitro screening of medicinal plants for their anti-inflammatory activity: an overview. J Appl Pharmaceut Sci 2012, 2:19-33.
• [22]Mohri I, Taniike M, Taniguchi M, Kanekiyo T, Aritake K, Inui T, Fukumoto N, Eguchi N, Kushi A, Sasai H, Kanaoka Y, Ozono K, Narumiya S, Suzuki K, Urade Y: Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 2006, 26:4383-4393.
• [23]Griggs J, Metcalfe JC, Hesketh R: Targeting tumour vasculature: the development of Combretastatin A4. Lancet Oncol 2001, 2:82-87.
• [24]Gelfand M, Mavai S, Drummond RB, Ndemera B: The Traditional Medical Practitioner in Zimbabwe: His Principles of Practice and Pharmacopoeia. Harare: Mambo Press; 1985:41.
• [25]Ojewole JA: Cardiovascular effects of mollic acid glucoside, a 1 alpha-hydroxycycloartenoid saponin extractive from Combretum molle (Combretaceae) leaf. Cardiovasc J South Af 2008, 19:128-134.
• [26]Naidoo Y, Heneidak S, Gairola S, Nicholas A, Naidoo G: The leaf secretory scales of Combretum molle (Combretaceae): morphology, ultrastructure and histochemistry. Plant Syst Evol 2012, 2012(298):25-32.
• [27]Lima L, Bastos L, Marcelo L, Fiebic I, de Oliveira P: Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediat Inflamm 2012, 2012:1-13. doi:10.1155/2012/946813
• [28]Cho HY, Kong KH: Molecular cloning expression, and characterization of a phi-type glutathione S-transferase from Oryza sativa. Pestic Biochem Physiol 2005, 83:29-36.
• [29]Azizi J, Ismail S, Mordi MN, Ramanathan S, Said MIM, Mansor MS: In vitro and in vivo effects of three different Mitragyna speciosa Korth leaf extracts on phase II drug metabolizing enzymes-Glutathione Transferases (GSTs). Molecules 2010, 15:432-441.
• [30]Schultz M, Dutta S, Tew KD: Inhibitors of glutathione Stransferases as therapeutic agents. Adv Drug Deliv Rev 1997, 26:91-104.
• [31]Musdal Y, Bolelli TE, Bolelli K, Yilmaz S, Ceyha D, Aksoy Y, Hegazy U, Mannervik B: Inhibition of human glutathione transferase P1-1 by novel benzazole derivatives. Tirk J Biochem 2012, 37:431-436.
• [32]Hayeshi R, Mutingwende I, Mavengere W, Masiyanise V, Mukanganyama S: The inhibition of hGST activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 2007, 45:286-295.
• [33]Kuby SA: A Study of Enzymes, Enzyme Catalysis, Kinetics and Substrate Binding, vol.1. USA: CRC press Florida; 1991:472.
• [34]Kolawole AO, Okonji RE, Ajele JO: Inhibition of glutathione S-transferases (GSTs) activity from cowpea storage bruchid, Callosobrochus maculatus Frabiricius by some plant extracts. Afr J Biotechnol 2009, 9:5516-5521.
• [35]Joo M, Sadikot RT: PGD synthase and PGD2 in immune response. Mediat Inflamm 2012, 2012:1-6. doi:10.1155/2012/503128
• [36]Rajakariah R, Hilliard M, Lawrence T, Trivedi S, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW: Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ 12–14 PGJ2. PNAS 2007, 104:20979-20984.
• [37]Jowsey IR, Thomson AM, Flanagan JU, Murdock PR, Moore GBT, Meyer DJ, Murphy GJ, Smith SA, Hayes JD: Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 2001, 359:507-516.